Ductal Carcinoma In Situ (DCIS) Pathology

  • DCIS is a proliferation of malignant epithelial cells:
    • Confined to the mammary ducts and without evidence of invasion through the basement membrane
  • They arise from ductal epithelium:
    • In the region of the terminal ductal–lobular unit
  • DCIS had previously been considered one stage in the continuum of histologic progression from ADH to invasive carcinoma:
    • It is now understood that DCIS comprises a heterogeneous group of lesions:
      • With variable histologic architecture, molecular and cellular characteristics, and clinical behavior (Figure)
  • Malignant cells proliferate until the ducts is obliterated:
    • There may be associated breakdown of the myoepithelial cell layer of the basement membrane surrounding the ductal lumen
  • DCIS has also been linked with changes in the surrounding stroma:
    • Resulting in fibroblast proliferation, lymphocyte infiltration, and angiogenesis
  • Thus, although the process is poorly understood:
    • Most, but not all, invasive ductal carcinomas are believed to arise from DCIS:
      • Therefore, DCIS is considered a nonobligate precursor of invasive breast carcinoma with a variable risk of progression:
        • Depending on a combination of pathologic factors:
          • These factors include:
            • Growth pattern, histologic grade, presence or absence of necrosis, size of the lesion, margin status, and expression of tumor biomarkers (estrogen and progesterone receptors)
Ductal carcinoma in situ (DCIS). Architectural heterogeneity is a common feature of DCIS. Even in the same lesion, DCIS may show different growth patterns. The most common patterns include (A) Cribriform, (B) Micropapillary, (C) Papillary and (D) Solid.
  • Common growth patterns of DCIS include:
    • Solid, cribriform, micropapillary, and papillary
    • Cribriform, solid, and micropapillary:
      • Are the more common subtypes:
        • Two or more patterns coexist in up to 50% of cases
  • Nuclear grading is based on:
    • The size, texture, and nucleoli
  • Similar to invasive carcinoma, three grades are recognized for DCIS:
    • Low-grade lesions:
      • Are characterized by a proliferation of monotonous cells with well-defined cell borders:
        • Uniformity of nuclear features is the key feature
    • Intermediate grade lesions:
      • Have nuclear features are in between low and high grade:
        • Central (comedo) necrosis is most frequently associated with high-grade lesions:
          • Less frequently found in intermediate lesions and very rarely present in low-grade lesions
    • High-grade DCIS is composed of pleomorphic cells with variable nuclear size and shape:
      • Mitoses are frequent in individual cells and comedonecrosis is common
    • Both the World Health Organization (WHO) and the College of American Pathologists (CAP):
      • Recommend that architectural and nuclear features and the presence of comedonecrosis should be evaluated independently of one another and all of these features should be included in pathology reports
  • Since DCIS only rarely forms a grossly visible mass:
    • Measurement of lesion size is typically done by microscopic evaluation:
      • The pathologist must be able to reconstruct the specimen to estimate size of the lesion:
        • This is a difficult task and requires that the histologic sections be submitted in orderly fashion to permit such reconstruction:
          • Even so, it is sometimes difficult to assess lesion size when small foci of DCIS are scattered throughout the resected specimen:
            • As most recurrences of DCIS probably represent persistence of DCIS following incomplete removal:
              • The evaluation of margins is not trivial
        • Routine specimen mammography and careful sectioning of the specimen are required
        • The most common approach involves the application of different colored inks to the surfaces of a specimen that has been oriented by the surgeon
        • The specimen is then submitted for histologic examination in serial sections and the shortest distance between DCIS and the inked margin is reported as the margin width
  • In a joint consensus statement, the Society of Surgical Oncology (SSO), the American Society for Radiation Oncology (ASTRO), and the American Society of Clinical Oncology (ASCO):
    • Recommended the margin width for breast-conserving surgery for DCIS to be 2 mm based on data from patients treated with adjuvant whole-breast radiation:
      • A 2-mm margin was determined after comparison to narrower margin widths demonstrated a significant decrease in in-breast recurrence:
        • However, the panel recommended exercising clinical judgment based on other clinical and imaging factors when determining the need for reoperation for re-excision for patients with margins < 2 mm
  • In addition to tumor factors:
    • Stromal features have also been found to be prognostic in DCIS lesions:
      • The presence of periductal fibrosis has been associated with increased likelihood of recurrence
      • Stromal tumor-infiltrating lymphocytes (TILs):
        • Have been found to be associated with:
          • Younger age, larger tumor size, higher nuclear grade, comedonecrosis, and estrogen receptor negative status
  • Given all of these considerations, the pathology report in cases of DCIS should include a large amount of data:
    • The College of American Pathologists (CAP) has recommended use of a template form to ensure that all histopathologic data are reported:
      • Such a form would typically include histologic pattern, nuclear grade, presence of necrosis, distance to margin, size, presence of calcifications, and status of estrogen and progesterone receptor expression

Leave a comment